Photo by jontyson from unsplash
To examine whether prostate‐specific antigen doubling time (PSADT) correlates with metastases, all‐cause mortality (ACM), and prostate cancer‐specific mortality (PCSM) and to identify PSADT thresholds that can be used clinically for… Click to show full abstract
To examine whether prostate‐specific antigen doubling time (PSADT) correlates with metastases, all‐cause mortality (ACM), and prostate cancer‐specific mortality (PCSM) and to identify PSADT thresholds that can be used clinically for risk stratification in men with M0 castration‐resistant prostate cancer (CRPC).
Keywords:
prostate;
prostate cancer;
doubling time;
castration resistant;
resistant prostate
Journal Title: BJU International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: BJU International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!